Ryvu Therapeutics
Please note: The information displayed on this page might be outdated.
Ryvu Therapeutics :
Developer of targeted oncology therapies hematology/solid tumors. RVU120 is wholly-owned first-in-class oral CDK8/19 inhibitor in Phase I for AML/MDS with start-up of Phase Ib in solid tumors expected 3Q 2021. Company has small molecule, synthetic lethality platform in pre-clinical development including novel targets WRN and PRMT5. Ryvu's PIM/FLT3 kinase inhibitor in Phase 1/2 is partnered with Menarini.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Immuno-Oncology, Oncology
Industry
Biotechnology, Pharmaceuticals
Investment Strategy
Under the Radar
Listing
Public
Therapeutic Modalities
Gene Therapy, Small Molecule
Website:
Profiles:
Address:
2 Sternbacha Street
Kraków, 30-394
Poland
Kraków, 30-394
Poland
More info:
My account:
Company Participants at Solebury Trout Hamptons CEO Roundtable 2021
- Vatnak Vat-Ho, Chief Business Officer
Top 10 Holders of Ryvu Therapeutics SA
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Nationale-Nederlanden PTE SA | 9.65 | 1,771,000 | 0.00 | Stakes | 5/17/22 |
| PTE PZU SA | 9.64 | 2,227,905 | 0.00 | Funds | 12/30/22 |
| Norges Bank Investment Management | 7.90 | 1,827,400 | 0.00 | Funds | 12/31/22 |
| Allianz Polska TFI SA | 7.31 | 1,689,419 | 0.00 | Stakes | 1/18/23 |
| Allianz Polska PTE SA | 6.63 | 1,532,540 | 0.00 | Stakes | 12/30/22 |
| FORUM TFI SA | 6.17 | 1,132,713 | 0.00 | Stakes | 5/17/22 |
| Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SA | 0.00 | 0 | 0.00 | Stakes | 12/30/22 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.